Literature DB >> 20556798

Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum.

Verena Matejas1, Bernward Hinkes, Faisal Alkandari, Lihadh Al-Gazali, Ellen Annexstad, Mehmet B Aytac, Margaret Barrow, Kveta Bláhová, Detlef Bockenhauer, Hae Il Cheong, Iwona Maruniak-Chudek, Pierre Cochat, Jörg Dötsch, Priya Gajjar, Raoul C Hennekam, Françoise Janssen, Mikhail Kagan, Ariana Kariminejad, Markus J Kemper, Jens Koenig, Jillene Kogan, Hester Y Kroes, Eberhard Kuwertz-Bröking, Amy F Lewanda, Ana Medeira, Jutta Muscheites, Patrick Niaudet, Michel Pierson, Anand Saggar, Laurie Seaver, Mohnish Suri, Alexey Tsygin, Elke Wühl, Aleksandra Zurowska, Steffen Uebe, Friedhelm Hildebrandt, Corinne Antignac, Martin Zenker.   

Abstract

Mutations of LAMB2 typically cause autosomal recessive Pierson syndrome, a disorder characterized by congenital nephrotic syndrome, ocular and neurologic abnormalities, but may occasionally be associated with milder or oligosymptomatic disease variants. LAMB2 encodes the basement membrane protein laminin beta2, which is incorporated in specific heterotrimeric laminin isoforms and has an expression pattern corresponding to the pattern of organ manifestations in Pierson syndrome. Herein we review all previously reported and several novel LAMB2 mutations in relation to the associated phenotype in patients from 39 unrelated families. The majority of disease-causing LAMB2 mutations are truncating, consistent with the hypothesis that loss of laminin beta2 function is the molecular basis of Pierson syndrome. Although truncating mutations are distributed across the entire gene, missense mutations are clearly clustered in the N-terminal LN domain, which is important for intermolecular interactions. There is an association of missense mutations and small in frame deletions with a higher mean age at onset of renal disease and with absence of neurologic abnormalities, thus suggesting that at least some of these may represent hypomorphic alleles. Nevertheless, genotype alone does not appear to explain the full range of clinical variability, and therefore hitherto unidentified modifiers are likely to exist. Copyright 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20556798      PMCID: PMC2978072          DOI: 10.1002/humu.21304

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  32 in total

Review 1.  Translational readthrough induction of pathogenic nonsense mutations.

Authors:  Richard Kellermayer
Journal:  Eur J Med Genet       Date:  2006-05-19       Impact factor: 2.708

Review 2.  The functions of laminins: lessons from in vivo studies.

Authors:  M C Ryan; A M Christiano; E Engvall; U M Wewer; J H Miner; J R Sanes; R E Burgeson
Journal:  Matrix Biol       Date:  1996-12       Impact factor: 11.583

3.  Mapping of a congenital microcoria locus to 13q31-q32.

Authors:  C Rouillac; O Roche; D Marchant; L Bachner; A Kobetz; P J Toulemont; C Orssaud; M Urvoy; S Odent; B Le Marec; M Abitbol; J L Dufier
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

Review 4.  Laminin-11.

Authors:  J H Miner; B L Patton
Journal:  Int J Biochem Cell Biol       Date:  1999-08       Impact factor: 5.085

5.  Pierson syndrome: a novel cause of congenital nephrotic syndrome.

Authors:  Rene' VanDeVoorde; David Witte; Jillene Kogan; Jens Goebel
Journal:  Pediatrics       Date:  2006-07-24       Impact factor: 7.124

6.  Variable phenotype of Pierson syndrome.

Authors:  Hyun Jin Choi; Beom Hee Lee; Ju Hyung Kang; Hyoen Joo Jeong; Kyung Chul Moon; Il Soo Ha; Young Suk Yu; Verena Matejas; Martin Zenker; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

7.  Analysis of genes encoding laminin beta2 and related proteins in patients with Galloway-Mowat syndrome.

Authors:  Andreas Dietrich; Verena Matejas; Martin Bitzan; Seema Hashmi; Cathy Kiraly-Borri; Shuan-Pei Lin; Eva Mildenberger; Bernd Hoppe; Lars Palm; Takashi Shiihara; Jens-Oliver Steiss; Jeng-Daw Tsai; Udo Vester; Stefanie Weber; Elke Wühl; Kristina Zepf; Martin Zenker
Journal:  Pediatr Nephrol       Date:  2008-07-02       Impact factor: 3.714

8.  Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities.

Authors:  Martin Zenker; Thomas Aigner; Olaf Wendler; Tim Tralau; Horst Müntefering; Regina Fenski; Susanne Pitz; Valérie Schumacher; Brigitte Royer-Pokora; Elke Wühl; Pierre Cochat; Raymonde Bouvier; Cornelia Kraus; Karlheinz Mark; Henry Madlon; Jörg Dötsch; Wolfgang Rascher; Iwona Maruniak-Chudek; Thomas Lennert; Luitgard M Neumann; André Reis
Journal:  Hum Mol Genet       Date:  2004-09-14       Impact factor: 6.150

9.  Laminin polymerization induces a receptor-cytoskeleton network.

Authors:  H Colognato; D A Winkelmann; P D Yurchenco
Journal:  J Cell Biol       Date:  1999-05-03       Impact factor: 10.539

10.  Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome.

Authors:  R A Maselli; J J Ng; J A Anderson; O Cagney; J Arredondo; C Williams; H B Wessel; H Abdel-Hamid; R L Wollmann
Journal:  J Med Genet       Date:  2009-03       Impact factor: 6.318

View more
  94 in total

1.  A missense LAMB2 mutation causes congenital nephrotic syndrome by impairing laminin secretion.

Authors:  Ying Maggie Chen; Yamato Kikkawa; Jeffrey H Miner
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

2.  Glomerular basement membrane and related glomerular disease.

Authors:  Ying Maggie Chen; Jeffrey H Miner
Journal:  Transl Res       Date:  2012-04-10       Impact factor: 7.012

3.  Genetic abnormalities and prognosis in patients with congenital and infantile nephrotic syndrome.

Authors:  Onur Cil; Nesrin Besbas; Ali Duzova; Rezan Topaloglu; Amira Peco-Antić; Emine Korkmaz; Fatih Ozaltin
Journal:  Pediatr Nephrol       Date:  2015-02-27       Impact factor: 3.714

4.  Retrospective mutational analysis of NPHS1, NPHS2, WT1 and LAMB2 in children with steroid-resistant focal segmental glomerulosclerosis - a single-centre experience.

Authors:  Agnieszka Bińczak-Kuleta; Jacek Rubik; Mieczysław Litwin; Małgorzata Ryder; Klaudyna Lewandowska; Olga Taryma-Leśniak; Jeremy S Clark; Ryszard Grenda; Andrzej Ciechanowicz
Journal:  Bosn J Basic Med Sci       Date:  2014-05       Impact factor: 3.363

Review 5.  The nature and biology of basement membranes.

Authors:  Ambra Pozzi; Peter D Yurchenco; Renato V Iozzo
Journal:  Matrix Biol       Date:  2016-12-28       Impact factor: 11.583

6.  Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases.

Authors:  Janina Müller-Deile; Jan Dannenberg; Patricia Schroder; Meei-Hua Lin; Jeffrey H Miner; Rongjun Chen; Jan-Hinrich Bräsen; Thomas Thum; Jenny Nyström; Lynne Beverly Staggs; Hermann Haller; Jan Fiedler; Johan M Lorenzen; Mario Schiffer
Journal:  Kidney Int       Date:  2017-05-03       Impact factor: 10.612

Review 7.  Basement membranes: cell scaffoldings and signaling platforms.

Authors:  Peter D Yurchenco
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

Review 8.  Genetic causes of proteinuria and nephrotic syndrome: impact on podocyte pathobiology.

Authors:  Oleh Akchurin; Kimberly J Reidy
Journal:  Pediatr Nephrol       Date:  2014-03-02       Impact factor: 3.714

Review 9.  Basement membranes in the cornea and other organs that commonly develop fibrosis.

Authors:  Paramananda Saikia; Carla S Medeiros; Shanmugapriya Thangavadivel; Steven E Wilson
Journal:  Cell Tissue Res       Date:  2018-10-03       Impact factor: 5.249

10.  NPHS2 p.V290M mutation in late-onset steroid-resistant nephrotic syndrome.

Authors:  Andrea Kerti; Rózsa Csohány; Attila Szabó; Ottó Arkossy; Péter Sallay; Vincent Moriniére; Virginia Vega-Warner; Gábor Nyírő; Orsolya Lakatos; Tamás Szabó; Beata S Lipska; Franz Schaefer; Corinne Antignac; George Reusz; Tivadar Tulassay; Kálmán Tory
Journal:  Pediatr Nephrol       Date:  2012-12-14       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.